68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 90 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 21,662 followers.

A separate prospective PSMA PET study (detection rate 54% at median PSA 0.61) showed oligomets (1-3 lesions) identified in 46%! https://t.co/a1KBrTB2tp

05 May 2019

Reply Repost Favourite

RT @AzadOncology: @_ShankarSiva @ChrisSweens1 @gu_onc @DrewMoghanaki @AlbertoBossial @DrAndrewLoblaw @DrSpratticus @JimCatto @JAMAOnc @DrMH…

03 Feb 2019

Reply Repost Favourite

@_ShankarSiva @ChrisSweens1 @gu_onc @DrewMoghanaki @AlbertoBossial @DrAndrewLoblaw @DrSpratticus @JimCatto @JAMAOnc @DrMHofman Interesting data. Initial take: 1. Relatively small study. Authors acknowledge under-powered for primary endpoint. 2. On PSMA-PET

02 Feb 2019

Reply Repost Favourite

68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy "Another study confirming utility of psma PET in BCR" https://t.co/sWuyLmYU2l

27 Oct 2018

Reply Repost Favourite

68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. https://t.co/nMYj1XW4DP

24 Oct 2018

Reply Repost Favourite